Volker Schirrmacher

from Wikipedia, the free encyclopedia

Volker Schirrmacher (born January 9, 1943 in Wentorf near Hamburg ) is a German cancer researcher and immunologist .

Schirrmacher studied biochemistry at the University of Tübingen from 1962 to 1967 and then went to the University of Cologne , where he received his doctorate in immunology in 1970 (with a thesis on the interaction of T cells and B cells ). As a post-doctoral student he was in Solna near Stockholm at the Karolinska Institute until 1973 and then in London at the London Hospital Medical College, where he dealt with basic research in immunology (e.g. transplant immunology and immunogenetics). In 1976 he became Scientific Councilor and Professor of Immunology at the German Cancer Research Center in Heidelberg, where he headed the cellular immunology department. In 1979 he completed his habilitation in immunology in Heidelberg and in 1986 he became a full professor.

In 1987/88 he was chairman of the Experimental Cancer Research Section (SEK) at the German Cancer Society and in 1989/80 he was President of the Metastasis Research Society. In 2003/2004 he represented Germany at the European Association of Cancer Research (EACR). From 2009 to 2011 he was President of the European Society for Applied Immunology eV (EGAI). He has been retired since 2008. Since then he has been Scientific Director of Tumor Immunology at the Immunological Oncological Center (IOZK) in Cologne. His scientific oeuvre includes more than 384 publications in international journals.

In the 1980s, he researched the cancer metastasis process and cancer immunotherapies (such as virus-modified immunotherapy). Viruses, which are harmless to humans, are reproduced outside the body in the cancer cells taken from the patient, the cancer cells are inactivated and these are then re-injected. The intention is to use the viruses to additionally activate the patient's immune system against the cancer cells. The process has also been tried in clinical trials.

In 1982 he received the Aronson Prize and the Meyenburg Prize and in 1988 the German Cancer Prize .

Fonts

  • as publisher: cancer - tumors, cells, genes . Spektrum Akademischer Verlag, Heidelberg 1986, ISBN 3-922508-38-3 .
  • Quo vadis cancer therapy? Fascinating discoveries of the last 60 years. Lambert Academic Publishing, 2017, ISBN 978-620-2-05545-1 .

Web links

Individual evidence

  1. EGAI eV
  2. Schirrmacher cancer vaccination with tumor cells , Spectrum of Science, January 1990
  3. Press release German Cancer Research Center 2004